Frank Luh
American Cancer Society(US)
Publications by Year
Research Areas
RNA modifications and cancer, Epigenetics and DNA Methylation, Cancer-related Molecular Pathways, Mitochondrial Function and Pathology, Analytical Chemistry and Chromatography
Most-Cited Works
- → Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials(2024)164 cited
- → Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers(2017)115 cited
- The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.(2003)
- → Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer(2018)54 cited
- → Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker(2016)46 cited
- → Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis(2016)46 cited
- → A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma(2020)42 cited
- → Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway(2019)41 cited
- → FDA guidance for next generation sequencing-based testing: balancing regulation and innovation in precision medicine(2018)37 cited
- → Overexpression of Uridine-Cytidine Kinase 2 Correlates with Breast Cancer Progression and Poor Prognosis(2017)33 cited